A 52 Week Study to Evaluate the Effects of Losartan With or Without HCTZ on Plasma Glucose, Metabolic Parameters, Blood Pressure in Hypertensive Patients With Metabolic Syndrome (0954A-331)

NCT00546052 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1738

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension
Metabolic Disorder

Interventions

DRUG: losartan potassium (+) hydrochlorothiazide

Sponsor

Organon and Co